Thrombus Formation during Intracranial Aneurysm Coil Placement: Treatment with Intra-Arterial Abciximab

References

1. ↵
   F Vinuela, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997;86:475–482

   PubMedWeb of Science
2. Eskridge JM, Song JK. Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils: results of the Food and Drug Administration multicenter clinical trial. J Neurosurg 1998;89:81–86

   PubMedWeb of Science
3. ↵
   Cognard C, Weill A, Castaings L, et al. Intracranial berry aneurysms: angiographic and clinical results after endovascular treatment. Radiology 1998;206:499–510

   PubMedWeb of Science
4. Debrun GM, Aletich VA, Kehrli P, et al., Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience. Neurosurgery 1998;43:1281–1295; discussion 1296–1297

   CrossRefPubMedWeb of Science
5. ↵
   Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol 1998;19:1541–1547

   Abstract
6. ↵
   Workman, MJ, Cloft HJ, Tong FC, et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol 2002;23:1568–1576

   Abstract/FREE Full Text
7. ↵
   Alexander MJ, Duckwiler GR, Gobin YP, et al. Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 2002;50:899–901; discussion 901–902

   CrossRefPubMedWeb of Science
8. ↵
   Cronqvist M, Pierot L, Boulin A, et al. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol 1998;19:157–165

   Abstract
9. ↵
   Ng PP, Phatouros CC, Khangure MS. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 2001;22:1761–1763

   Abstract/FREE Full Text
10. ↵
    Lempert TE, Malek AM, Halbach VV, et al. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999;30:693–695

    FREE Full Text
11. ↵
    Blankenship JC, Hellkamp AS, Aguirre FV, et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol 1998;81:36–40

    CrossRefPubMedWeb of Science
12. Gammie JS, Zenati M, Kormos RL, et al. Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg 1998;65:465–469

    CrossRefPubMedWeb of Science
13. ↵
    Ferguson JJ, Kereiakes DJ, Adgey AA, et al. Safe use of platelet GP IIb/IIIa inhibitors. Am Heart J 1998;135:S77–S89

    CrossRefPubMed
14. ↵
    Derdeyn CP, Cross DT III, Moran CJ, et al. Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg 2002;96:837–843

    PubMedWeb of Science
15. ↵
    Murayama Y, Vinuela F, Tateshima S, et al. Cellular responses of bioabsorbable polymeric material and Guglielmi detachable coil in experimental aneurysms. Stroke 2002;33:1120–1128

    Abstract/FREE Full Text
16. Murayama, Y, Vinuela F, Tateshima S, et al. Bioabsorbable polymeric material coils for embolization of intracranial aneurysms: a preliminary experimental study. J Neurosurg 2001;94:454–463

    CrossRefPubMedWeb of Science
17. ↵
    Kallmes DF, Fujiwara NH. New expandable hydrogel-platinum coil hybrid device for aneurysm embolization. AJNR Am J Neuroradiol 2002;23:1580–1588

    Abstract/FREE Full Text
18. ↵
    Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization: the EPILOG Investigators. N Engl J Med 1997;336:1689–1696

    CrossRefPubMedWeb of Science
19. ↵
    Ghaffari S, Kereiakes DJ, Lincoff AM, et al. Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy: EPILOG Investigators—Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade. Am J Cardiol 1998;82:7–12

    CrossRefPubMedWeb of Science
20. ↵
    Li Y, Spencer FA, Ball S, et al. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes. J Thromb Thrombolysis 2000;10:69–76
21. ↵
    Moser M, Bertram U, Peter K, et al. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. J Cardiovasc Pharmacol 2003;41:586–592

    CrossRefPubMedWeb of Science
22. ↵
    Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999;99:3050–3055

    Abstract/FREE Full Text